108 related articles for article (PubMed ID: 845874)
1. In vitro O-demethylation of the psychotomimetic amine, 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane.
Zweig JS; Castagnoli N
J Med Chem; 1977 Mar; 20(3):414-21. PubMed ID: 845874
[TBL] [Abstract][Full Text] [Related]
2. Metabolic O-demethylation of the psychotomimetic amine 1-(2, 5-dimetroxy-4-methylphenyl)-2-aminopropane.
Zwieg JS; Castagnoli N
Psychopharmacol Commun; 1975; 1(4):359-71. PubMed ID: 1224005
[TBL] [Abstract][Full Text] [Related]
3. Chemical and biological studies of 1-(2,5-dihydroxy-4-methylphenyl)-2-aminopropane, an analogue of 6-hydroxydopamine.
Jacob P; Kline T; Castagnoli N
J Med Chem; 1979 Jun; 22(6):662-71. PubMed ID: 458821
[TBL] [Abstract][Full Text] [Related]
4. In vitro stereoselective metabolism of the psychotomimetic amine, 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane. An apparent enantiomeric interaction.
McGraw NP; Callery SC; Castagnoli N
J Med Chem; 1977 Feb; 20(2):185-9. PubMed ID: 836489
[TBL] [Abstract][Full Text] [Related]
5. Studies on chiral interactions of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane and the corresponding N-hydroxy metabolites with cytochrome P-450.
McGraw NP; Castagnoli N
J Med Chem; 1981 Mar; 24(3):299-304. PubMed ID: 7265116
[TBL] [Abstract][Full Text] [Related]
6. N-Hydroxylation of 1-(2,5-demethoxy-4-methylphenyl)-2-aminopropane by rabbit liver microsomes.
Gal J; Gruenke LD; Castagnoli N
J Med Chem; 1975 Jul; 18(7):683-8. PubMed ID: 1151987
[TBL] [Abstract][Full Text] [Related]
7. Monomethylthio analogues of 1-(2,4,5-trimethoxyphenyl)-2-aminopropane.
Jacob P; Anderson G; Meshul CK; Shulgin AT; Castagnoli N
J Med Chem; 1977 Oct; 20(10):1235-9. PubMed ID: 903913
[TBL] [Abstract][Full Text] [Related]
8. Chemical conversion of the psychotomimetic amine 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane to 5-hydroxy-2,6-dimethylindole.
Zweig JS; Castagnoli N
J Med Chem; 1974 Jul; 17(7):747-9. PubMed ID: 4836406
[No Abstract] [Full Text] [Related]
9. Substituent branching in phenethylamine-type hallucinogens: a comparison of 1-[2,5-dimethoxy-4-(2-butyl)phenyl]-2-aminopropane and 1-[2,5-dimethoxy-4-(2-methylpropyl)phenyl]-2-aminopropane.
Oberlender RA; Kothari PJ; Nichols DE; Zabik JE
J Med Chem; 1984 Jun; 27(6):788-92. PubMed ID: 6737421
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) on schedule-controlled behavior.
Harris RA; Snell D; Loh HH
Pharmacol Biochem Behav; 1977 Oct; 7(4):307-10. PubMed ID: 928488
[TBL] [Abstract][Full Text] [Related]
11. Metabolic fate of 2,5-dimethoxy-4-methylamphetamine in the guinea pig and rabbit.
Nagamatsu K; Kido Y; Urakubo G
Chem Pharm Bull (Tokyo); 1978 Apr; 26(4):1267-73. PubMed ID: 657412
[No Abstract] [Full Text] [Related]
12. Phenylakylamines with potential psychotherapeutic utility. 1. 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)butane.
Standridge RT; Howell HG; Gylys JA; Partyka RA; Shulgin AT
J Med Chem; 1976 Dec; 19(12):1400-4. PubMed ID: 1003425
[No Abstract] [Full Text] [Related]
13. Conformational energy differences between side chain alkylated analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane.
Weintraub HJ; Nichols DE; Makriyannis A; Fesik SW
J Med Chem; 1980 Mar; 23(3):339-41. PubMed ID: 7365752
[TBL] [Abstract][Full Text] [Related]
14. Sulfur analogues of psychotomimetic agents. 2. Analogues of (2,5-dimethoxy-4-methylphenyl)-and (2,5-dimethoxy-4-ethylphenyl)isopropylamine.
Jacob P; Shulgin AT
J Med Chem; 1983 May; 26(5):746-52. PubMed ID: 6842515
[TBL] [Abstract][Full Text] [Related]
15. Demethyl analogues of psychoactive methoxyphenalkylamines: synthesis and serotonin receptor affinities.
Glennon RA; Liebowitz SM; Leming-Doot D; Rosecrans JA
J Med Chem; 1980 Sep; 23(9):990-4. PubMed ID: 7411554
[TBL] [Abstract][Full Text] [Related]
16. Resolution and absolute configuration of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, a potent hallucinogen analogue.
Nichols DE; Woodard R; Hathaway BA; Lowy MT; Yom KW
J Med Chem; 1979 Apr; 22(4):458-60. PubMed ID: 430485
[TBL] [Abstract][Full Text] [Related]
17. Indolealkylamine and phenalkylamine hallucinogens. Effect of alpha-methyl and N-methyl substituents on behavioral activity.
Glennon RA; Young R; Jacyno JM
Biochem Pharmacol; 1983 Apr; 32(7):1267-73. PubMed ID: 6573879
[TBL] [Abstract][Full Text] [Related]
18. 2,5-Dimethoxyamphetamine-derived designer drugs: studies on the identification of cytochrome P450 (CYP) isoenzymes involved in formation of their main metabolites and on their capability to inhibit CYP2D6.
Ewald AH; Maurer HH
Toxicol Lett; 2008 Dec; 183(1-3):52-7. PubMed ID: 18938231
[TBL] [Abstract][Full Text] [Related]
19. Stereochemical aspects and metabolite formation in the in vivo metabolism of the psychotomimetic amine, 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane.
Matin SB; Callery PS; Zweig JS; O'Brien A; Rapoport R; Castagnoli N
J Med Chem; 1974 Aug; 17(8):877-82. PubMed ID: 4845381
[No Abstract] [Full Text] [Related]
20. Synthesis and evaluation of 2,3-dihydrobenzofuran analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane: drug discrimination studies in rats.
Nichols DE; Hoffman AJ; Oberlender RA; Riggs RM
J Med Chem; 1986 Feb; 29(2):302-4. PubMed ID: 3950910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
